By admin 
The investigation is reportedly exploring two primary avenues of potential misconduct. The first involves Epic’s controversial use of non-compete agreements and restrictive employment clauses that prevent its former workers from seeking employment with a vast network of healthcare businesses, including competitors, consulting firms, and even the hospitals that use Epic’s software. The second line of inquiry focuses on the more technical and systemic issue of "information blocking"—the practice of using a dominant market position to prevent rival technology companies from accessing the patient data and software interfaces necessary to compete effectively. These two issues, while distinct, paint a picture of a "walled garden" ecosystem that critics argue has allowed Epic to maintain its dominance not just through the quality of its product, but through the strategic exclusion of rivals.
To understand the weight of this investigation, one must first grasp the sheer scale of Epic Systems. Founded in 1979 by Judy Faulkner in a basement in Wisconsin, Epic has grown into a multi-billion-dollar private entity headquartered on a sprawling, whimsical campus in Verona. Unlike its publicly traded competitors, Epic has never been beholden to quarterly earnings reports or the demands of outside investors, allowing it to maintain a singular, often rigid focus on its integrated software suite. Today, Epic’s software is used by the most prestigious medical institutions in the country, including the Mayo Clinic, Johns Hopkins, and the Cleveland Clinic. According to data from KLAS Research, Epic holds roughly 36% of the acute care hospital market share, but its influence is even greater when measured by patient volume; because it serves the largest academic medical centers, more than 300 million people worldwide have their medical records stored on an Epic system.
This dominance has created what economists call a "network effect." As more large health systems adopt Epic, it becomes increasingly difficult for any single hospital to choose a different vendor, as they want to ensure seamless data sharing with neighboring facilities. However, the FTC is reportedly investigating whether this seamlessness is a byproduct of genuine interoperability or a result of "lock-in" tactics. Rival software developers—ranging from small AI startups to specialized diagnostic tool makers—have long complained that Epic makes it prohibitively expensive or technically difficult to integrate their products into the Epic environment. While Epic maintains an "App Orchard" (now called Showroom) to facilitate some integrations, critics argue that the company acts as a gatekeeper, charging high fees and imposing restrictive terms that prevent third-party innovators from scaling.
The labor component of the FTC’s probe is equally significant. For years, Epic has been known for its strict employment contracts. The company’s non-compete agreements have been described as some of the most aggressive in the tech world, often barring former employees from working for any company that interfaces with Epic for a period of one to two years. Given that Epic’s software is the standard for a huge portion of the healthcare industry, these restrictions effectively "blackball" former employees from a wide swath of the job market. This practice has come under fire from the Biden administration and FTC Chair Lina Khan, who has made the elimination of non-compete agreements a cornerstone of her regulatory agenda. In April 2024, the FTC issued a final rule to ban most non-compete agreements nationwide, arguing they suppress wages and stifle entrepreneurship, though that rule has faced significant legal challenges in federal courts. The specific inquiry into Epic suggests that the FTC is looking at how these labor restrictions might be used specifically to maintain a monopoly in the healthcare IT sector.
Industry experts suggest that the FTC’s interest in Epic may also be linked to the broader push for healthcare interoperability mandated by the 21st Century Cures Act. This federal law, passed with overwhelming bipartisan support, was designed to end the "siloing" of medical data. The Office of the National Coordinator for Health Information Technology (ONC) has since implemented rules that penalize "information blocking." If the FTC finds that Epic has been intentionally complicating the process for patients or providers to move data to other platforms, it could lead to substantial fines or mandated changes to Epic’s business model.
The investigation comes at a time when the healthcare industry is at a crossroads regarding artificial intelligence. As AI becomes more integrated into clinical decision-making, the company that controls the data—the "fuel" for AI—holds immense power. If Epic uses its position to favor its own AI tools over those developed by independent researchers or competitors, it could shape the future of medical practice for decades. "The concern is that Epic is becoming the ‘Amazon’ of healthcare," said one industry consultant who spoke on the condition of anonymity. "They aren’t just a platform; they are the landlord, the gatekeeper, and a competitor all at once. When you control the pipes through which all the data flows, you have the power to decide who wins and who loses in the next generation of health tech."
Epic, for its part, has historically defended its practices by emphasizing the security and integrity of its "one patient, one record" philosophy. The company argues that a highly integrated, tightly controlled system is necessary to prevent medical errors, protect patient privacy, and ensure that doctors have a comprehensive view of a patient’s history. Faulkner has famously resisted the "fragmentation" of health data, arguing that allowing too many third-party integrations could compromise the stability of the system. Epic also points to its participation in Carequality, a national framework for data exchange, as evidence of its commitment to interoperability. According to Epic’s own metrics, millions of patient records are exchanged daily between its systems and those of other vendors.
However, the FTC’s investigation suggests that the government is no longer willing to take those claims at face value. Investigators are reportedly looking into whether Epic’s participation in such exchanges is performative or if the company still maintains subtle barriers that make it harder for competitors to thrive. For instance, the "Epic-to-Epic" transfer of data is often seamless, but transferring data from an Epic system to a smaller, rival EHR vendor can be fraught with technical hurdles and additional costs, often passed down to the healthcare provider.
The potential outcomes of this probe are varied. In the best-case scenario for Epic, the FTC may find no evidence of illegal behavior and close the file. However, if the agency finds evidence of anticompetitive conduct, it could lead to a formal lawsuit seeking to "unbundle" certain services, force changes to Epic’s contracting practices, or even demand that the company open its APIs (Application Programming Interfaces) more broadly to competitors. In extreme cases, antitrust regulators have the power to seek a breakup of dominant companies, though such an outcome for a private software firm like Epic would be unprecedented and legally complex.
As the FTC continues its interviews with hospital executives, former Epic employees, and rival tech CEOs, the healthcare industry is watching closely. The outcome of this investigation will likely set a precedent for how the government regulates the digital infrastructure of modern medicine. For years, Epic has operated with a level of autonomy that few other companies of its size enjoy. Now, it faces the most significant challenge to its business model in its 45-year history. The question at the heart of the probe is whether the "Epic-ization" of American healthcare has been a triumph of efficiency or a masterclass in monopolistic control. As federal investigators dig deeper into the code and the contracts that power our hospitals, the answer to that question could redefine the boundaries of competition in the digital age.
